Vor Biopharma Inc - Asset Resilience Ratio

Latest as of June 2026: 74.48%

Vor Biopharma Inc (VOR) has an Asset Resilience Ratio of 74.48% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See working capital to net assets of Vor Biopharma Inc to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

$358.27 Million

Cash + Short-term Investments

Total Assets

$481.05 Million

All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2020–2025)

This chart shows how Vor Biopharma Inc's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see Vor Biopharma Inc total assets.

Liquid Assets Composition Over Time

This chart breaks down Vor Biopharma Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read VOR liabilities breakdown for a breakdown of total debt and financial obligations.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	$0.00	0%
Short-term Investments	$358.27 Million	74.48%
Total Liquid Assets	$358.27 Million	74.48%

Asset Resilience Insights

Very High Liquidity: Vor Biopharma Inc maintains exceptional liquid asset reserves at 74.48% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

Vor Biopharma Inc Industry Peers by Asset Resilience Ratio

Compare Vor Biopharma Inc's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
ALK-Abelló A/S CO:ALK-B	Biotechnology	0.98%
Mirum Pharmaceuticals Inc NASDAQ:MIRM	Biotechnology	6.89%
Xiamen Amoytop Biotech Co Ltd SHG:688278	Biotechnology	4.69%
BB Biotech AG SW:BION	Biotechnology	92.97%
Soleno Therapeutics Inc NASDAQ:SLNO	Biotechnology	20.15%
Nanobiotix NASDAQ:NBTX	Biotechnology	4.71%
Wuhan Keqian Biology Co Ltd SHG:688526	Biotechnology	19.42%
Beijing Konruns Pharmaceutical Co Ltd SHG:603590	Biotechnology	10.55%

Annual Asset Resilience Ratio for Vor Biopharma Inc (2020–2025)

The table below shows the annual Asset Resilience Ratio data for Vor Biopharma Inc.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	12.65%	$58.72 Million	$464.13 Million	+5.67pp
2024-12-31	6.98%	$9.98 Million	$142.89 Million	-43.45pp
2023-12-31	50.43%	$105.81 Million	$209.83 Million	-7.21pp
2022-12-31	57.63%	$172.54 Million	$299.37 Million	+21.50pp
2021-12-31	36.14%	$87.67 Million	$242.59 Million	--
2020-12-31	0.00%	$0.00	$75.91 Million	--

pp = percentage points

About Vor Biopharma Inc

NASDAQ:VOR USA Biotechnology

Market Cap

$1.30 Billion

Market Cap Rank

#7811 Global

#2326 in USA

Share Price

$21.89

Change (1 day)

-0.27%

52-Week Range

$6.86 - $48.72

All Time High

$54.08